Latest News
Latest News
  • Home
  • Video Shows
    VantageFirstpost AmericaFirstpost AfricaFirst Sports
  • World
    US News
  • Explainers
  • News
    IndiaOpinionCricketTechEntertainmentSportsHealthPhotostories
TrendingDonald TrumpNarendra ModiElon MuskUnited StatesJoe Biden
Latest News

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit

Covaxin News

Recent Highlights

Explained: The measures that Bharat Biotech will take in response to WHO’s suspension of Covaxin

Explained: The measures that Bharat Biotech will take in response to WHO’s suspension of Covaxin

.
Covaxin 50% effective against Delta variant, shows Lancet study

Covaxin 50% effective against Delta variant, shows Lancet study

.
Bharat Biotech's Covaxin's phase three data shows 65.2% efficacy against Delta variant of COVID-19, says Lancet

Bharat Biotech's Covaxin's phase three data shows 65.2% efficacy against Delta variant of COVID-19, says Lancet

.
UK to add Bharat Biotech's Covaxin to approved list for in-bound flyers from 22 November

UK to add Bharat Biotech's Covaxin to approved list for in-bound flyers from 22 November

.

All Stories for Covaxin News

All (7)
  • Bharat Biotech seeks approval for Covaxin in US for children below 18 years

    Bharat Biotech seeks approval for Covaxin in US for children below 18 years

    • .

    Clinical trials were conducted on 526 kids during which no serious adverse events or hospitalisations were observed

  • Covaxin gets shelf life extension of up to 12 months from manufacturing date, says Bharat Biotech

    Covaxin gets shelf life extension of up to 12 months from manufacturing date, says Bharat Biotech

    Fp Staff • .

    The approval of extension of shelf life by the Central Drugs Standard Control Organisation was based on the 'additional stability data', Bharat Biotech tweeted

  • Bharat Biotech's Covaxin awaits feedback from WHO on Emergency Use Listing

    Bharat Biotech's Covaxin awaits feedback from WHO on Emergency Use Listing

    • .

    The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet "to be confirmed," according to the update available on WHO website.

  • Home
  • covaxin news

About Firstpost

Most Searched Categories

  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025

NETWORK18 SITES

  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
youtube
youtube

is on YouTube

Subscribe Now

Copyright @ 2025. Firstpost - All Rights Reserved.

Contact Us Privacy Policy Cookie Policy Terms Of Use
HomeVideosShortsLive TV